Annual Total Liabilities
$41.82 M
-$42.74 M-50.54%
December 31, 2023
Summary
- As of February 12, 2025, RPTX annual total liabilities is $41.82 million, with the most recent change of -$42.74 million (-50.54%) on December 31, 2023.
- During the last 3 years, RPTX annual total liabilities has fallen by -$28.44 million (-40.48%).
- RPTX annual total liabilities is now -71.90% below its all-time high of $148.82 million, reached on December 31, 2019.
Performance
RPTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$31.43 M
-$237.00 K-0.75%
September 30, 2024
Summary
- As of February 12, 2025, RPTX quarterly total liabilities is $31.43 million, with the most recent change of -$237.00 thousand (-0.75%) on September 30, 2024.
- Over the past year, RPTX quarterly total liabilities has dropped by -$21.61 million (-40.74%).
- RPTX quarterly total liabilities is now -79.28% below its all-time high of $151.70 million, reached on March 31, 2020.
Performance
RPTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RPTX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.5% | -40.7% |
| 3 y3 years | -40.5% | -59.4% |
| 5 y5 years | +15.2% | - |
RPTX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.5% | at low | -69.6% | +1.0% |
| 5 y | 5-year | -71.9% | at low | -79.3% | +1.0% |
| alltime | all time | -71.9% | +15.2% | -79.3% | +1.0% |
Repare Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $31.43 M(-0.7%) |
| Jun 2024 | - | $31.67 M(+1.7%) |
| Mar 2024 | - | $31.13 M(-25.6%) |
| Dec 2023 | $41.82 M(-50.5%) | $41.82 M(-21.2%) |
| Sep 2023 | - | $53.04 M(-5.6%) |
| Jun 2023 | - | $56.17 M(-34.0%) |
| Mar 2023 | - | $85.06 M(+0.6%) |
| Dec 2022 | $84.56 M | $84.56 M(-18.2%) |
| Sep 2022 | - | $103.38 M(+25.3%) |
| Jun 2022 | - | $82.53 M(+5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $78.49 M(-2.2%) |
| Dec 2021 | $80.29 M(+14.3%) | $80.29 M(+3.7%) |
| Sep 2021 | - | $77.39 M(+2.4%) |
| Jun 2021 | - | $75.56 M(+5.8%) |
| Mar 2021 | - | $71.42 M(+1.6%) |
| Dec 2020 | $70.26 M(-52.8%) | $70.26 M(+1.2%) |
| Sep 2020 | - | $69.44 M(+2.0%) |
| Jun 2020 | - | $68.08 M(-55.1%) |
| Mar 2020 | - | $151.70 M(+1.9%) |
| Dec 2019 | $148.82 M(+309.9%) | $148.82 M |
| Dec 2018 | $36.31 M | - |
FAQ
- What is Repare Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Repare Therapeutics?
- What is Repare Therapeutics annual total liabilities year-on-year change?
- What is Repare Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Repare Therapeutics?
- What is Repare Therapeutics quarterly total liabilities year-on-year change?
What is Repare Therapeutics annual total liabilities?
The current annual total liabilities of RPTX is $41.82 M
What is the all time high annual total liabilities for Repare Therapeutics?
Repare Therapeutics all-time high annual total liabilities is $148.82 M
What is Repare Therapeutics annual total liabilities year-on-year change?
Over the past year, RPTX annual total liabilities has changed by -$42.74 M (-50.54%)
What is Repare Therapeutics quarterly total liabilities?
The current quarterly total liabilities of RPTX is $31.43 M
What is the all time high quarterly total liabilities for Repare Therapeutics?
Repare Therapeutics all-time high quarterly total liabilities is $151.70 M
What is Repare Therapeutics quarterly total liabilities year-on-year change?
Over the past year, RPTX quarterly total liabilities has changed by -$21.61 M (-40.74%)